RAC 2.20% $1.78 race oncology ltd

General Comments / Chat, page-8830

  1. 311 Posts.
    lightbulb Created with Sketch. 417
    Maybe something for the Monash discovery program if ALKBH5 is still on the cards. I noticed only FTO was mentioned in the strategic update.

    ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes
    https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.42676
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.